|
1
|
Terek RM, Schwartz GK, Devaney K, et al:
Chemotherapy and P-glycoprotein expression in chondrosarcoma. J
Orthop Res. 16:585–590. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hiraoka K, Zenmyo M, Komiya S, et al:
Relationship of p21(waf1/cip1) and differentiation in
chondrosarcoma cells. Virchows Arch. 440:285–290. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schrage YM, Briaire-de Bruijn IH, de
Miranda NF, et al: Kinome profiling of chondrosarcoma reveals
SRC-pathway activity and dasatinib as option for treatment. Cancer
Res. 69:6216–6222. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
DeLaney TF, Liebsch NJ, Pedlow FX, et al:
Phase II study of high-dose photon/proton radiotherapy in the
management of spine sarcomas. Int J Radiat Oncol Biol Phys.
74:732–739. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goila-Gaur R and Strebel K: HIV-1 Vif,
APOBEC, and intrinsic immunity. Retrovirology. 5:512008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Heidmann T, Heidmann O and Nicolas JF: An
indicator gene to demonstrate intracellular transposition of
defective retroviruses. Proc Natl Acad Sci USA. 85:2219–2223. 1988.
View Article : Google Scholar
|
|
7
|
Macduff DA and Harris RS: Directed DNA
deamination by AID/APOBEC3 in immunity. Curr Biol. 16:R186–R189.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Conticello SG: The AID/APOBEC family of
nucleic acid mutators. Genome Biol. 9:2292008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Burns MB, Lackey L, Carpenter MA, et al:
APOBEC3B is an enzymatic source of mutation in breast cancer.
Nature. 494:366–370. 2013.PubMed/NCBI
|
|
10
|
Refsland EW, Stenglein MD, Shindo K, Albin
JS, Brown WL and Harris RS: Quantitative profiling of the full
APOBEC3 mRNA repertoire in lymphocytes and tissues:
implications for HIV-1 restriction. Nucleic Acids Res.
38:4274–4284. 2010.PubMed/NCBI
|
|
11
|
Burns MB, Temiz NA and Harris RS: Evidence
for APOBEC3B mutagenesis in multiple human cancers. Nat Genet.
45:977–983. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim DW, Kim KO, Shin MJ, et al:
siRNA-based targeting of antiapoptotic genes can reverse
chemoresistance in P-glycoprotein expressing chondrosarcoma cells.
Mol Cancer. 8:282009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nishida K, Furumatsu T, Takada I, et al:
Inhibition of human chondrosarcoma cell growth via apoptosis by
peroxisome proliferator-activated receptor-γ. Br J Cancer.
86:1303–1309. 2002.PubMed/NCBI
|
|
14
|
Jin Z, Han YX and Han XR: Loss of RUNX3
expression may contribute to poor prognosis in patients with
chondrosarcoma. J Mol Histol. 44:645–652. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu R, Zhang X, Zhang W, Fang Y, Zheng S
and Yu XF: Association of human APOBEC3 cytidine deaminases with
the generation of hepatitis virus B x antigen mutants and
hepatocellular carcinoma. Hepatology. 46:1810–1820. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chiu YL and Greene WC: The APOBEC3
cytidine deaminases: an innate defensive network opposing exogenous
retroviruses and endogenous retroelements. Annu Rev Immunol.
26:317–353. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han YX and Liang DY: The role of the tumor
suppressor RUNX3 in giant cell tumor of the bone. Int J Oncol.
40:673–678. 2011.PubMed/NCBI
|
|
18
|
Holmes RK, Koning FA, Bishop KN and Malim
MH: APOBEC3F can inhibit the accumulation of HIV-1 reverse
transcription products in the absence of hypermutation. Comparisons
with APOBEC3G. J Biol Chem. 282:2587–2595. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iwatani Y, Chan DS, Wang F, et al:
Deaminase-independent inhibition of HIV-1 reverse transcription by
APOBEC3G. Nucleic Acids Res. 35:7096–7108. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mbisa JL, Barr R, Thomas JA, et al: Human
immunodeficiency virus type 1 cDNAs produced in the presence of
APOBEC3G exhibit defects in plus-strand DNA transfer and
integration. J Virol. 81:7099–7110. 2007. View Article : Google Scholar
|
|
21
|
Lawrence MS, Stojanov P, Polak P, et al:
Mutational heterogeneity in cancer and the search for new
cancer-associated genes. Nature. 499:214–218. 2013. View Article : Google Scholar : PubMed/NCBI
|
